Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy

Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency

NCT05505955 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Primary Membranous Nephropathy (ZL-1103-014)

NCT05810961 ·Status: TERMINATED ·Phase: PHASE2

A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy

NCT05668403 ·Status: RECRUITING ·Phase: PHASE1

Pharmacokinetic/Pharmacokinetic and Safety Studies of SHR4640 in Subjects With Moderate Renal Insufficiency and Healthy Subjects

NCT05954169 ·Status: COMPLETED ·Phase: PHASE1

Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy

NCT02662283 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

A Study of SHR4010 in Patients With Hemodialysis

NCT04099927 ·Status: COMPLETED ·Phase: PHASE1

A Trial of HR19042 Capsule in Healthy Chinese Subjects

NCT04887532 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease

NCT04492722 ·Status: TERMINATED ·Phase: PHASE2

Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

NCT02282930 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

NCT05797610 ·Status: RECRUITING ·Phase: PHASE3

A Study of SHR0410 in Hemodialysis Patients With Pruritus

NCT04317209 ·Status: UNKNOWN ·Phase: PHASE1

Safety and Efficacy Study of the Effect of Etanercept in Hemodialysis Patients

NCT00293202 ·Status: TERMINATED ·Phase: PHASE2

Study of Telitacicept in Patients With Refractory IgA Nephropathy

NCT05596708 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency

NCT04020328 ·Status: UNKNOWN ·Phase: PHASE4

Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis

NCT02063100 ·Status: UNKNOWN ·Phase: PHASE4

A Study of CCX140-B in Subjects With Primary FSGS and Nephrotic Syndrome

NCT03703908 ·Status: TERMINATED ·Phase: PHASE2

Pharmacokinetics of ZSP1273 in Participants With Severe Kidney Disease

NCT06248567 ·Status: COMPLETED ·Phase: PHASE1

A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy

NCT05174221 ·Status: COMPLETED ·Phase: PHASE1

A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy

NCT05707377 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases

NCT04950114 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of REGN9035 in Healthy Adult Volunteers and Mildly Hypertensive Participants

NCT05291546 ·Status: COMPLETED ·Phase: PHASE1

Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients

NCT04578834 ·Status: COMPLETED ·Phase: PHASE3

Membranous Nephropathy-associated Serological Antibody Predict the Prognosis of Idiopathic Membranous Nephropathy

NCT03475602 ·Status: TERMINATED

Clinical Study of Rituximab Combined With Corticosteroids or Rituximab Monotherapy in the Treatment of Primary Membranous Nephropathy

NCT05514015 ·Status: RECRUITING ·Phase: PHASE4

Study of FG-4592 in Subjects With Chronic Kidney Disease in China

NCT01599507 ·Status: COMPLETED ·Phase: PHASE2